Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy

BJU International

Volumn 95, Issue 6, 2005, Pages 843-846

  Mydlo, Jack H ^a,b   Viterbo, Rosalia ^a   Crispen, Paul ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Combined therapy; Erectile dysfunction; Injection; Prostate cancer

Indexed keywords

ANDROGEN; APOMORPHINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE; VARDENAFIL;

ADJUVANT THERAPY; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; DERMATITIS; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; AGED; ALPROSTADIL; DRUG THERAPY, COMBINATION; HUMANS; IMIDAZOLES; IMPOTENCE, VASCULOGENIC; INJECTIONS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POSTOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SULFONES; TRIAZINES; VASODILATOR AGENTS;

EID: 17444432211     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05413.x     Document Type: Conference Paper

References (25)

1. Lue TF. Erectile dysfunction. N Eng J Med 2000; 342: 1802-13
2. Walsh PC, Retik AB, Vaughn ED, eds. Campbell's Urology, 8th edn. Philadelphia: WB Saunders, 2002: 1653-5
3. Williams G, Abbou CC, Amar ET et al. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. Br J Urol 1998; 81: 889-94
4. Padma-Nathan H, Hellstrom WJ, Kaiser FE et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Eng J Med 1997; 336: 1-7
5. Werthman P, Rajfer J. MUSE therapy: preliminary clinical observations. Urology 1998; 50: 874-82
6. Costabile RA, Spevak M, Fishman IJ et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998; 160: 1325-8
7. Marks LS, Duda C, Dorey FJ et al. Treatment of erectile dysfunction with sildenafil. Urology 1999; 53: 19-24
8. Zippe CD, Jhaveri FM, Klein EA et al. Role of Viagra after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998; 52: 963-6
9. Gralnek D, Wessells H, Cui H, Dalkin BL. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol 2000; 163: 1166-70
10. Zagaja GP, Mhoon DA, Aikens JE et al. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000; 56: 631-4
11. Mydlo JH, Volpe MA, Macchia RI. Initial results utilizing combination therapy in patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol 2000; 38: 30-4
12. Mydlo JH, Volpe MA, Macchia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int 2000; 86: 1-6
13. McMahon CG. Erectile dysfunction. Med J Australia 2000; 173: 492-7
14. McMahon CG, Samali R, Johnson H. Treatment of intracorporal injection non-response with sildenafil alone or in combination with triple intracorporal injection therapy. J Urol 1999; 162: 1992-8
15. Shabsigh R. Hyogonadism and erectile dysfunction: the role of testosterone therapy. Int J Impotence Res 2003; 15: S9-13
16. Shabsigh R, Anastasiadis AG. Erectile dysfunction. Ann Rev Med 2003; 54: 153-68
17. Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R, Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate in treated and untreated patients with depression. Urology 2002; 60: 58-66
18. Nehra A, Steers WD, Althof SE et al. Third International Conference on the Management of Erectile Dysfunction: linking Pathophysiology and Therapeutic response. J Urol 2003; 170: S3-5
19. Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998; 52: 739-43
20. Carter BH et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. The Prostate 1995; 27: 25-31
21. Anastasiadis AG, Ghafar MA, Burchardt M, Shabsigh R. Economic aspects of medical erectile dysfunction therapies. Expert Opinion Pharmacotherapy 2002; 3: 257-63
22. Baniel J, Israilov S, Segenreich E, Livne PM. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. BJU Int 2001; 88: 58-62
23. Rhoden EL, Morgentaler A. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer. Results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol 2003; 170: 2348-51
24. Atiemo HO, Szostak MJ, Sklar GN. Salvage of sildenafil failures referred from primary care physicians. J Urol 2003; 170: 2356-8
25. Jaffe JS, Antell MR, Greenstein M, Ginsberg PC, Mydlo JH, Harkaway RC. Use of intraurethral alprostadil in patients not responding to sildenafil citrate. Urology 2004; 63: 951-4